MIN-301

N/A

Report date: 2022/03/10 15:56:54

Base Information

Drug NameMIN-301
Drug Alias NameMIN-301NRG-101
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionReceptor protein-tyrosine kinase erbB-4 agonists
TargetsReceptor protein-tyrosine kinase erbB-4
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesProteosys Ag
China Registration ClassN/A

Develop Information

Active CompaniesProteosys AgMinerva Neurosciences Inc
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A